Hosking Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-42,550
Closed -$2.72M 119
2023
Q2
$2.72M Buy
42,550
+2,909
+7% +$195K 0.12% 103
2023
Q1
$2.75M Sell
39,641
-7,488
-16% -$528K 0.13% 109
2022
Q4
$3.39M Sell
47,129
-55,148
-54% -$4.16M 0.14% 102
2022
Q3
$7.27M Sell
102,277
-7,450
-7% -$540K 0.32% 79
2022
Q2
$8.45M Sell
109,727
-20,692
-16% -$1.58M 0.33% 75
2022
Q1
$9.52M Sell
130,419
-2,778
-2% -$187K 0.25% 89
2021
Q4
$8.3M Sell
133,197
-2,520
-2% -$148K 0.2% 102
2021
Q3
$8.03M Sell
135,717
-14,923
-10% -$983K 0.2% 100
2021
Q2
$10.1M Sell
150,640
-2,084
-1% -$136K 0.22% 99
2021
Q1
$9.64M Sell
152,724
-5,697
-4% -$354K 0.23% 99
2020
Q4
$9.83M Sell
158,421
-5,299
-3% -$326K 0.25% 91
2020
Q3
$9.87M Sell
163,720
-5,538
-3% -$333K 0.3% 80
2020
Q2
$9.95M Sell
169,258
-11,913
-7% -$713K 0.31% 85
2020
Q1
$10.1M Sell
181,171
-5,280
-3% -$323K 0.35% 72
2019
Q4
$12M Sell
186,451
-6,567
-3% -$376K 0.29% 86
2019
Q3
$9.79M Sell
193,018
-9,079
-4% -$427K 0.25% 92
2019
Q2
$9.16M Sell
202,097
-864
-0.4% -$40.2K 0.22% 101
2019
Q1
$9.68M Sell
202,961
-1,040
-0.5% -$51.8K 0.25% 100
2018
Q4
$10.6M Sell
204,001
-7,565
-4% -$406K 0.3% 85
2018
Q3
$13.1M Sell
211,566
-6,212
-3% -$369K 0.29% 89
2018
Q2
$12.1M Buy
217,778
+1,576
+0.7% +$85.1K 0.27% 95
2018
Q1
$13.7M Buy
216,202
+9,243
+4% +$595K 0.3% 85
2017
Q4
$12.7M Buy
206,959
+14,440
+8% +$903K 0.29% 88
2017
Q3
$12.3M Buy
192,519
+591
+0.3% +$34.5K 0.32% 84
2017
Q2
$10.7M Buy
191,928
+3,094
+2% +$168K 0.28% 86
2017
Q1
$10.3M Buy
188,834
+16,958
+10% +$930K 0.29% 86
2016
Q4
$10M Sell
171,876
-4,445
-3% -$243K 0.32% 79
2016
Q3
$9.51M Buy
176,321
+21,112
+14% +$1.36M 0.32% 83
2016
Q2
$11.4M Buy
155,209
+20,626
+15% +$1.46M 0.47% 62
2016
Q1
$8.6M Buy
134,583
+9,992
+8% +$630K 0.39% 72
2015
Q4
$8.57M Buy
124,591
+1,586
+1% +$105K 0.4% 71
2015
Q3
$7.28M Buy
+123,005
New +$7.8M 0.36% 77

Other funds holding BMY